HIV-associated salivary gland disease

Last revised by Daniel J Bell on 22 Sep 2023

HIV-associated salivary gland disease is a condition characterized by lymphatic infiltration of the salivary glands, especially the parotids. This condition of HIV patients can be part of the diffuse infiltrative lymphocytosis syndrome. The condition is one of the most important AIDS-associated oral lesions.

The incidence of HIV-associated salivary gland disease has been reported to be as high 48% in developing territories in those with HIV-1 infections 3.

HIV-associated salivary gland disease generally presents with:

As a consequence of HIV infection, lymphoid infiltration into the gland, along with lymphoid epithelial lesion development are responsible for salivary gland enlargement and xerostomia 4.

The benign lymphoepithelial/myoepithelial lesions of HIV-associated salivary gland disease comprise intranodal cysts lined with epithelial cells.

Radiological features are non-specific.

  • usually bilateral salivary gland enlargement with intraglandular cystic and solid masses

  • increase in size and number of cervical lymph nodes 2

Antiretroviral therapy was useful in the treatment of HIV-related lymphoepithelial parotid cysts 4. There is reportedly a good prognosis in children 2.

HIV-associated salivary gland disease was first used by Schiødt to characterize a swelling of major salivary glands with a complaint of dry mouth in patients with HIV, in absence of xerogenic agents or medications 3.

ADVERTISEMENT: Supporters see fewer/no ads

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.